Skip to main content

Table 6 Survival subgroups defined by survival in each treatment arm

From: Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

TCV survival groups (n = 22)

TC low

TCV intermediate

TCV high

Number of cases

9

8

5

Median overall survival (months)

9

31

60

DCV survival groups (n = 17)

DCV low

DCV intermediate

DCV high

Number of cases

6

6

5

Median overall survival (months)

15

43

60

  1. TCV tumor cell vaccine, DCV dendritic cell vaccine